Summary for ARTG Entry:
SORTINE Isosorbide mononitrate 60mg modified release tablet bottle
ARTG entry for
Medis Pharma Pty Ltd
PO Box 6127,North Sydney, NSW, 2059
ARTG Start Date
4/04/2012 11:00:00 PM
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. SORTINE Isosorbide mononitrate 60mg modified release tablet bottle
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Prophylactic treatment of angina pectoris. SORTINE 60mg Sustained Release tablets are not recommended for the management of acute attacks of
Additional Product information
Store below 30
Protect from Moisture
Protect from Light
Pack Size/Poison information
(S4) Prescription Only Medicine
1. Medicine Component
Tablet, modified release
Route of Administration
Oval tablet with a cream coloured film coating and half scored on both
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 05:24:16 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information